Allena Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Allena Pharmaceuticals

11/05/2021 16:39

* Allena Pharmaceuticals Inc  ALNA.OQ  reported a quarterly
adjusted loss of 21 cents​​ per share for the quarter ended
in March. The mean expectation of four analysts for the quarter
was for a loss of 23 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Allena Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 21 cents​.
* The mean earnings estimate of analysts had fallen by about 23%
in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Allena Pharmaceuticals Inc shares had fallen by 20.9% this
quarter and lost 14.1% so far this year.
* The company reported a quarterly loss of $11.64 million.
* Wall Street's median 12-month price target for Allena
Pharmaceuticals Inc is $6.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 03:39 p.m. GMT.
​All figures in US dollars